Arch Therapeutics Inc (ARTH) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arch Therapeutics Inc   (ARTH)


Arch Therapeutics Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Arch Therapeutics Inc's ROI in the third quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Arch Therapeutics Inc 's return on investment (ROI) in its third quarter of 2024

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2024)
III. Quarter		 (Mar 31 2024)
II. Quarter		 (Dec 31 2023)
I. Quarter		 (Sep 30 2023)
IV. Quarter		 (Jun 30 2023)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -13 -11 -10 -8 -8
Return On Investment (TTM) - - - - -
ARTH's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -8 -8 -7 -6

ARTH Company Profile >> Back to ARTH Roi Comparisons >> See Annual ARTH Return On Investment



Return On Investment ARTH's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Arch Therapeutics Inc's III. Quarter Investments $ -13 Millions ARTH's Balance sheet
Arch Therapeutics Inc's III. Quarter Income $ -6 Millions Quarterly ARTH's Income Statement
ARTH's Income by Division See ARTH's Income by Division


ARTH Annual Return On Investment (Sep 30 2023)
2023		 (Sep 30 2022)
2022		 (Sep 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019
Total Investments in Millions -8 -1 2 2 2
Y / Y Investment Growth - - 29.52 % -31.24 % -51.92 %
Net Income in Millions -7 -5 -6 -5 -5
Y / Y Net Income Growth - - - - -
Annual Return On Investment - - -320.19 % -311.76 % -207.8 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARTH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARTH's Competitors
Subscribers only: Roi for Arch Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ARTH's Customers

Other Ratios
ARTH's Roa ARTH's Inventory Turnover Ratio ARTH's Growth Rates ARTH's Dividend Statistics
ARTH's Profitability Ratios ARTH's Asset Turnover Ratio ARTH's Dividend Growth
ARTH's Roe ARTH's Valuation Ratios ARTH's Financial Strength Ratios ARTH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector ROI
Interpace Biosciences Inc   243.24 %
WEED, INC.  238.52 %
Alaunos Therapeutics Inc   152.92 %
Camp4 Therapeutics Corporation  84.34 %
Roivant Sciences Ltd   77.20 %
Earth Science Tech Inc   73.25 %
Mimedx Group Inc   57.35 %
Guardion Health Sciences Inc   55.97 %
Biomx Inc  52.39 %
Entrada Therapeutics Inc   50.42 %
Siga Technologies Inc  50.32 %
Dariohealth Corp   50.05 %
Entera Bio Ltd   48.24 %
Scienture Holdings Inc   43.00 %
Protagonist Therapeutics inc   37.74 %
Mettler toledo International Inc   36.92 %
Medpace Holdings Inc   36.84 %
Valion Bio Inc   36.78 %
Nrc Health  36.51 %
Idexx Laboratories Inc  36.50 %
Pharmacyte Biotech Inc   36.30 %
Elite Pharmaceuticals Inc   33.34 %
Exelixis Inc   32.02 %
Johnson and Johnson  30.31 %
Sbc Medical Group Holdings Incorporated  28.61 %
Lantheus Holdings Inc   28.19 %
Cyclerion Therapeutics Inc   28.07 %
Lite Strategy Inc   27.58 %
Carlisle Companies Incorporated  25.54 %
Cytomx Therapeutics Inc   25.09 %

Date modified: 2026-09-12T06:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.